MedPageToday -- GOTHENBURG, Sweden -- The monoclonal antibody laquinimod has multiple mechanisms of action in both the central nervous system and the periphery, investigators in two phase III studies reported here.
MedPageToday -- GOTHENBURG, Sweden -- The monoclonal antibody laquinimod has multiple mechanisms of action in both the central nervous system and the periphery, investigators in two phase III studies reported here.
